Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Resignation of Ms Maithilee Mistry as Chief Financial Officer of the Company w.e.f. May 05, 2025.

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹4781.14

prior close

₹4656.05

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-4.3%+3.7% vs market

Pharmaceuticals peers, median of 147sector-3.9%+3.3% vs sector

On the reaction day the stock moved 3.7 pts more than Nifty Microcap 250 and 3.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.7

10m

+1.7

15m

+1.7

30m

+1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6-4.3+3.7-3.9+3.3

Next day

+2.0-2.0+4.1-2.6+4.7

+2.1-3.3+5.4-4.0+6.1

+3.5+0.0+3.5-1.7+5.2

+3.6+3.3+0.3+1.1+2.4

+4.3+4.1+0.2+2.1+2.2

+3.3+6.5-3.2+3.4-0.1

15d

+3.3+2.4+0.9-0.3+3.7

+3.6+2.5+1.1-0.4+4.0

+6.8+17.4-10.6+6.8-0.1

+11.0+18.3-7.3+6.6+4.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sanofi Consumer Healthcare India has informed the stock exchange about the resignation of Ms. Maithilee Mistry from the post of Chief Financial Officer. Her resignation will take effect from May 05, 2025. The company has not yet announced a successor. The filing is a routine corporate governance disclosure under SEBI LODR norms.

Likely market impact

Investors should watch for the announcement of a new CFO, as a leadership gap in finance can briefly create uncertainty until a replacement is confirmed. For a large MNC subsidiary like Sanofi, the parent group typically fills such roles quickly, so long-term impact is likely limited.